The short version of derivatization fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-01-05 and is reviewed periodically as new material appears.
Quality control for glutathione materials checks identity, assay, purity, water content, and disulfide content. Commercial products vary from research-grade powder to dietary supplements, and labels may not distinguish reduced from oxidized forms. In the United States, oral glutathione is commonly sold as a dietary supplement rather than an approved drug, while injectable forms fall under different rules and may require a prescription. Regulatory status differs by country. Analytical certificates, when available, help verify what a material contains, but independent testing remains important for interpretation.
Laboratory measurement of glutathione typically starts with rapid acid extraction to prevent oxidation and enzymatic degradation. Common methods include enzymatic recycling assays, high-performance liquid chromatography, and liquid chromatography coupled with mass spectrometry. The recycling assay uses glutathione reductase and a thiol-reactive colorimetric or fluorescent reagent, measuring total glutathione after converting disulfide forms. Chromatographic methods can separate reduced and oxidized forms, which helps when the redox ratio is the target. Choice of method affects sensitivity, specificity, and the amount of sample needed.
Quality control for glutathione focuses on identity, purity, and oxidation state. Certificates of analysis may report assay value, water content, and the presence of GSSG or other impurities. Chromatographic purity is often expressed as a percentage of peak area. Reference standards help laboratories compare results across instruments and batches. Because glutathione is a small, polar molecule, separation from cysteine, gamma-glutamylcysteine, and related thiols can be challenging. Verification often combines more than one analytical technique.
Measuring glutathione requires attention to sample preparation because the molecule oxidizes readily. Blood, tissue, and cell samples are often treated with acid to precipitate proteins and stabilize the thiol. Without such steps, GSH can convert to GSSG or form mixed disulfides during storage. Analytical methods include spectrophotometric assays, high-performance liquid chromatography, and mass spectrometry. Each approach has different sensitivity, specificity, and susceptibility to interference from related compounds in complex matrices.
| Property | Value | Notes |
|---|---|---|
| Recommended storage | −20 °C, desiccated | For dry powder; limit light and air exposure |
| Solution stability | Hours to days at neutral pH | Faster loss at warm, alkaline, or oxygen-rich conditions |
| Routine measurement | LC-MS/MS or HPLC | Enzymatic recycling assays measure total glutathione |
| Thiol pKa | About 8.7 | The thiolate form reacts with oxidants and electrophiles |
| Common abbreviations | GSH and GSSG | GSSG is the disulfide-linked dimer |
Glutathione serves as a cofactor for several enzymes, including glutathione peroxidase and glutathione S-transferase. These enzymes help reduce hydrogen peroxide and lipid peroxides, and they conjugate reactive electrophiles for excretion. The molecule also acts as a reservoir for cysteine, an amino acid that is prone to oxidation. In addition, glutathione participates in the metabolism of nitric oxide, leukotrienes, and prostaglandins. Its roles extend to cell signaling, apoptosis, and the regulation of protein function through S-glutathionylation.
Glutathione is a tripeptide composed of glutamate, cysteine, and glycine, and it is the most abundant non-protein thiol in most living cells. The reduced form, GSH, carries a sulfhydryl group that can donate electrons, while the oxidized form, GSSG, forms when two GSH molecules link via a disulfide bond. The balance between these two forms helps define the cellular redox environment, and their ratio is often used as an indicator of oxidative stress. Because the sulfhydryl group is reactive, glutathione participates in many cellular processes, including detoxification and protein regulation.
Glutathione is synthesized in two ATP-dependent steps. First, gamma-glutamylcysteine synthetase links glutamate and cysteine; second, glutathione synthetase adds glycine to form the complete tripeptide. The pathway is feedback-inhibited by GSH itself, which helps maintain steady intracellular levels. Tissues vary widely in glutathione content, with the liver typically containing the highest concentrations, followed by the kidneys, lungs, and erythrocytes. Because cysteine is often limiting, its availability influences synthesis rates, and regulation of this pathway varies by cell type.
For solid glutathione reagents, storage at low temperature and protection from moisture and light are typical precautions. Aqueous solutions can oxidize over time, and pH affects stability; alkaline conditions generally promote thiol oxidation. Some protocols prepare fresh solutions, while others use antioxidants or chelators to limit metal-catalyzed oxidation. Purity and counterion content can vary among commercial preparations, affecting concentration calculations. Certificates of analysis and validated assays help verify identity and purity.
Measuring glutathione in biological samples requires attention to oxidation, because GSH can convert to GSSG after sample collection. Blood and plasma samples are often treated with acid or alkylating agents to preserve the reduced form. Without stabilization, apparent GSH concentrations can fall while GSSG rises. Differences in sample type, handling delay, and deproteinization method can produce results that are not comparable across studies. Reporting preanalytical details is therefore important for interpreting findings.
Common analytical approaches include enzymatic recycling assays, high-performance liquid chromatography, and mass spectrometry. Enzymatic recycling measures total glutathione after converting GSSG back to GSH, while separation methods can quantify GSH and GSSG separately. Derivatization may be used to improve detection or stability during analysis. LC-MS/MS offers high specificity and can distinguish glutathione from related thiols and adducts. Each method has different sensitivity, throughput, and susceptibility to interference, so method selection depends on the study question and sample matrix.
Storage conditions strongly influence glutathione stability. The solid reduced form is commonly kept desiccated at or below minus twenty degrees Celsius, protected from light and moisture. Aqueous solutions are less stable because the thiol group reacts with dissolved oxygen, and oxidation accelerates at neutral or alkaline pH. Acidic solutions and oxygen-free handling can slow degradation, but repeated freeze-thaw cycles should be avoided. Researchers often verify concentration before use, because apparent losses can arise from oxidation or water uptake.
Measuring glutathione in biological samples requires attention to oxidation and matrix effects. High-performance liquid chromatography with ultraviolet or fluorescence detection can separate reduced and oxidized forms after derivatization. Liquid chromatography with tandem mass spectrometry offers higher specificity and can quantify glutathione alongside related thiols. Because glutathione can oxidize during sample handling, many protocols use rapid acidification with metaphosphoric acid or sulfosalicylic acid. Internal standards help correct for losses during extraction and analysis.
Enzymatic recycling assays provide a complementary approach for total glutathione. In these methods, glutathione reductase reduces oxidized glutathione while a thiol-reactive reagent, such as 5,5'-dithiobis(2-nitrobenzoic acid), produces a colored product. The reaction cycles between reduced and oxidized forms, amplifying the signal. Spectrophotometric or fluorometric detection can then estimate concentration. Distinguishing reduced glutathione from glutathione disulfide often requires separate aliquots, masking agents, or chromatographic separation, and the choice affects reported values.
Stability depends on pH, temperature, oxygen exposure, and trace metals. Aqueous solutions of reduced glutathione are susceptible to oxidation, especially when neutral or alkaline and exposed to air. Transition metal ions can catalyze thiol oxidation, so chelators and inert atmospheres are sometimes used in research settings. Standards are typically stored cold and desiccated, with limited freeze-thaw cycles. Questions remain about how closely in vitro stability data reflect the behavior of glutathione within intact cells and tissues.
Measuring glutathione requires attention to oxidation during sample handling, because GSH in biological samples can convert to GSSG or form mixed disulfides with proteins after collection. Acidic extraction, rapid cooling, and chelating agents are commonly used to limit such changes. Analytical methods usually distinguish free reduced glutathione, total glutathione, and protein-bound forms. Because these forms have different stability and reactivity, reported values depend heavily on the preparation protocol. No single preparation is universally suitable for every biological matrix or analytical goal.
Several techniques are used for quantification. Enzymatic recycling assays rely on glutathione reductase and a colorimetric or fluorescent readout, offering sensitivity for total glutathione. High-performance liquid chromatography can separate GSH from GSSG and other thiols, often with UV, fluorescence, or electrochemical detection. Mass spectrometry provides structural confirmation and can quantify low-abundance species when paired with separation. Each approach has trade-offs in specificity, throughput, and equipment requirements, so method selection depends on the research question and available instrumentation.
The other settings were available to block out interference, but did so by also blocking some of the signal which reduced the overall sensitivity of the system. The output of the mixer was sent to the Y-axis deflection plates in a specially designed high-quality CRT. For reasons not well explained in the literature, this was arranged to deflect the beam downward with increasing signal. When combined with the X-axis signal from the time base generator, echoes received from distant objects caused the display to produce blips along the display. By measuring the centre point of the blip against a mechanical scale along the top of the display, the range to the target could be determined. This measurement was later aided by the addition of the calibrator unit or strobe, which caused additional sharp blips to be drawn every 10 miles (16 km) along the display. The markers were fed from the same electronic signals as the time base, so it was always properly calibrated.
Sugar is added to fruit to protect against microbial contamination and reduce water activity in the fruit. This allows the fruit to be more stable at room temperature. Some examples are strawberries, prunes, peaches, apricots, and pineapples. IMF blueberries are prepared by osmotic dehydration. They are soaked in sugar for one to two days followed by a freeze drying process until the desired moisture level is reached.
===== MeSH D08.811.277.656 – peptide hydrolases (EC 3.4) ===== MeSH D08.811.277.656.149 – atp-dependent proteases MeSH D08.811.277.656.149.200 – endopeptidase clp MeSH D08.811.277.656.149.500 – protease la MeSH D08.811.277.656.300 – endopeptidases MeSH D08.811.277.656.300.066 – aspartic endopeptidases MeSH D08.811.277.656.300.066.180 – cathepsin d MeSH D08.811.277.656.300.066.185 – cathepsin e MeSH D08.811.277.656.300.066.200 – chymosin MeSH D08.811.277.656.300.066.340 – HIV protease MeSH D08.811.277.656.300.066.700 – pepsin a MeSH D08.811.277.656.300.066.780 – renin MeSH D08.811.277.656.300.099 – brinolase MeSH D08.811.277.656.300.133 – cathepsins MeSH D08.811.277.656.300.133.062 – carboxypeptidase c MeSH D08.811.277.656.300.133.125 – cathepsin b MeSH D08.811.277.656.300.133.187 – cathepsin d MeSH D08.811.277.656.300.133.250 – cathepsin e MeSH D08.811.277.656.300.133.375 – dipeptidyl peptidase i MeSH D08.811.277.656.300.174 – coagulase MeSH D08.811.277.656.300.215 – cysteine endopeptidases MeSH D08.811.277.656.300.215.096 – bromelains MeSH D08.811.277.656.300.215.120 – calpain MeSH D08.811.277.656.300.215.126 – caspases MeSH D08.811.277.656.300.215.126.200 – caspase 1 MeSH D08.811.277.656.300.215.133 – cathepsin b MeSH D08.811.277.656.300.215.160 – chymopapain MeSH D08.811.277.656.300.215.350 – ficain MeSH D08.811.277.656.300.215.585 – papain MeSH D08.811.277.656.300.480 – metalloendopeptidases MeSH D08.811.277.656.300.480.205 – collagenases MeSH D08.811.277.656.300.480.205.352 – gelatinase a MeSH D08.811.277.656.300.480.205.360 – gelatinase b MeSH D08.811.277.656.300.480.205.410 – interstitial collagenase MeSH D08.811.277.656.300.480.205.500 – microbial collagenase MeSH D08.811.277.656.300.480.205.615 – neutrophil collagenase MeSH D08.811.277.656.300.480.252 – gelatinases MeSH D08.811.277.656.300.480.252.420 – gelatinase a MeSH D08.811.277.656.300.480.252.445 – gelatinase b MeSH D08.811.277.656.300.480.300 – insulysin MeSH D08.811.277.656.300.480.452 – lysostaphin MeSH D08.811.277.656.300.480.525 – matrix metalloproteinases MeSH D08.811.277.656.300.480.525.352 – gelatinase a MeSH D08.811.277.656.300.480.525.360 – gelatinase b MeSH D08.811.277.656.300.480.525.451 – interstitial collagenase MeSH D08.811.277.656.300.480.525.505 – matrilysin MeSH D08.811.277.656.300.480.525.615 – neutrophil collagenase MeSH D08.811.277.656.300.480.525.810 – stromelysin 1 MeSH D08.811.277.656.300.480.600 – neprilysin MeSH D08.811.277.656.300.480.632 – pregnancy-associated plasma protein-a MeSH D08.811.277.656.300.480.664 – procollagen n-endopeptidase MeSH D08.811.277.656.300.480.680 – pronase MeSH D08.811.277.656.300.480.827 – thermolysin MeSH D08.811.277.656.300.760 – serine endopeptidases MeSH D08.811.277.656.300.760.030 – acrosin MeSH D08.811.277.656.300.760.176 – chymotrypsin MeSH D08.811.277.656.300.760.198 – complement factor b MeSH D08.811.277.656.300.760.200 – complement factor d MeSH D08.811.277.656.300.760.210 – complement factor i MeSH D08.811.277.656.300.760.228 – endopeptidase clp MeSH D08.811.277.656.300.760.247 – endopeptidase k MeSH D08.811.277.656.300.760.284 – enteropeptidase MeSH D08.811.277.656.300.760.300 – factor viia MeSH D08.811.277.656.300.760.310 – factor ixa MeSH D08.811.277.656.300.760.315 – factor xa MeSH D08.811.277.656.300.760.320 – factor xia MeSH D08.811.277.656.300.760.324 – factor xiia MeSH D08.811.277.656.300.760.353 – furin MeSH D08.811.277.656.300.760.442 – kallikreins MeSH D08.811.277.656.300.760.442.700 – plasma kallikrein MeSH D08.811.277.656.300.760.442.725 – prekallikrein MeSH D08.811.277.656.300.760.442.750 – prostate-specific antigen MeSH D08.811.277.656.300.760.442.875 – tissue kallikreins MeSH D08.811.277.656.300.760.501 – mannose-binding protein-associated serine proteases MeSH D08.811.277.656.300.760.560 – pancreatic elastase MeSH D08.811.277.656.300.760.560.500 – leukocyte elastase MeSH D08.811.277.656.300.760.625 – plasmin MeSH D08.811.277.656.300.760.635 – plasminogen activators MeSH D08.811.277.656.300.760.635.075 – anistreplase MeSH D08.811.277.656.300.760.640 – proprotein convertase 1 MeSH D08.811.277.656.300.760.646 – proprotein convertase 2 MeSH D08.811.277.656.300.760.648 – proprotein convertase 5 MeSH D08.811.277.656.300.760.680 – pronase MeSH D08.811.277.656.300.760.733 – protease la MeSH D08.811.277.656.300.760.787 – subtilisins MeSH D08.811.277.656.300.760.787.805 – subtilisin MeSH D08.811.277.656.300.760.855 – thrombin MeSH D08.811.277.656.300.760.875 – tissue plasminogen activator MeSH D08.811.277.656.300.760.895 – trypsin MeSH D08.811.277.656.300.760.910 – urinary plasminogen activator MeSH D08.811.277.656.300.760.955 – venombin a MeSH D08.811.277.656.300.760.955.060 – ancrod MeSH D08.811.277.656.300.760.955.135 – batroxobin MeSH D08.811.277.656.300.775 – streptokinase MeSH D08.811.277.656.300.775.075 – anistreplase MeSH D08.811.277.656.300.775.900 – streptodornase and streptokinase MeSH D08.811.277.656.350 – exopeptidases MeSH D08.811.277.656.350.100 – aminopeptidases MeSH D08.811.277.656.350.100.150 – amino acid naphthylamidases MeSH D08.811.277.656.350.100.150.400 – leucyl-beta-naphthylamidase MeSH D08.811.277.656.350.100.160 – antigens, cd13 MeSH D08.811.277.656.350.100.235 – cystinyl aminopeptidase MeSH D08.811.277.656.350.100.373 – glutamyl aminopeptidase MeSH D08.811.277.656.350.100.511 – leucyl aminopeptidase MeSH D08.811.277.656.350.100.511.400 – leucyl-beta-naphthylamidase MeSH D08.811.277.656.350.100.755 – pyroglutamyl-peptidase I MeSH D08.811.277.656.350.245 – carboxypeptidases MeSH D08.811.277.656.350.245.055 – carboxypeptidases A MeSH D08.811.277.656.350.245.083 – carboxypeptidase B MeSH D08.811.277.656.350.245.111 – carboxypeptidase C MeSH D08.811.277.656.350.245.167 – carboxypeptidase H MeSH D08.811.277.656.350.245.224 – carboxypeptidase U MeSH D08.811.277.656.350.245.252 – Serine-type D-Ala-D-Ala carboxypeptidase MeSH D08.811.277.656.350.245.280 – gamma-glutamyl hydrolase MeSH D08.811.277.656.350.245.400 – glutamate carboxypeptidase ii MeSH D08.811.277.656.350.245.450 – lysine carboxypeptidase MeSH D08.811.277.656.350.245.500 – muramoylpentapeptide carboxypeptidase MeSH D08.811.277.656.350.297 – dipeptidases MeSH D08.811.277.656.350.350 – dipeptidyl peptidases MeSH D08.811.277.656.350.350.126 – antigens, cd26 MeSH D08.811.277.656.350.350.375 – dipeptidyl peptidase i MeSH D08.811.277.656.350.555 – metalloexopeptidases MeSH D08.811.277.656.350.555.100 – antigens, cd13 MeSH D08.811.277.656.350.555.200 – carboxypeptidase b MeSH D08.811.277.656.350.555.250 – carboxypeptidase h MeSH D08.811.277.656.350.555.300 – carboxypeptidase u MeSH D08.811.277.656.350.555.350 – carboxypeptidases a MeSH D08.811.277.656.350.555.400 – cystinyl aminopeptidase MeSH D08.811.277.656.350.555.500 – glutamate carboxypeptidase ii MeSH D08.811.277.656.350.555.600 – glutamyl aminopeptidase MeSH D08.811.277.656.350.555.700 – leucyl aminopeptidase MeSH D08.811.277.656.350.555.700.400 – leucyl-beta-naphthylamidase MeSH D08.811.277.656.350.555.750 – lysine carboxypeptidase MeSH D08.811.277.656.350.700 – peptidyl-dipeptidase a MeSH D08.811.277.656.675 – metalloproteases MeSH D08.811.277.656.675.374 – metalloendopeptidases MeSH D08.811.277.656.675.374.102 – adam proteins MeSH D08.811.277.656.675.374.205 – collagenases MeSH D08.811.277.656.675.374.205.352 – gelatinase a MeSH D08.811.277.656.675.374.205.360 – gelatinase b MeSH D08.811.277.656.675.374.205.410 – interstitial collagenase MeSH D08.811.277.656.675.374.205.500 – microbial collagenase MeSH D08.811.277.656.675.374.205.615 – neutrophil collagenase MeSH D08.811.277.656.675.374.252 – gelatinases MeSH D08.811.277.656.675.374.252.420 – gelatinase a MeSH D08.811.277.656.675.374.252.445 – gelatinase b MeSH D08.811.277.656.675.374.300 – insulysin MeSH D08.811.277.656.675.374.452 – lysostaphin MeSH D08.811.277.656.675.374.525 – matrix metalloproteinases MeSH D08.811.277.656.675.374.525.352 – gelatinase a MeSH D08.811.277.656.675.374.525.360 – gelatinase b MeSH D08.811.277.656.675.374.525.451 – interstitial collagenase MeSH D08.811.277.656.675.374.525.505 – matrilysin MeSH D08.811.277.656.675.374.525.615 – neutrophil collagenase MeSH D08.811.277.656.675.374.525.810 – stromelysin 1 MeSH D08.811.277.656.675.374.600 – neprilysin MeSH D08.811.277.656.675.374.632 – pregnancy-associated plasma protein-a MeSH D08.811.277.656.675.374.664 – procollagen n-endopeptidase MeSH D08.811.277.656.675.374.680 – pronase MeSH D08.811.277.656.675.374.827 – thermolysin MeSH D08.811.277.656.675.555 – metalloexopeptidases MeSH D08.811.277.656.675.555.100 – antigens, cd13 MeSH D08.811.277.656.675.555.200 – carboxypeptidase b MeSH D08.811.277.656.675.555.250 – carboxypeptidase h MeSH D08.811.277.656.675.555.300 – carboxypeptidase u MeSH D08.811.277.656.675.555.350 – carboxypeptidases a MeSH D08.811.277.656.675.555.400 – cystinyl aminopeptidase MeSH D08.811.277.656.675.555.500 – glutamate carboxypeptidase ii MeSH D08.811.277.656.675.555.600 – glutamyl aminopeptidase MeSH D08.811.277.656.675.555.700 – leucyl aminopeptidase MeSH D08.811.277.656.675.555.700.400 – leucyl-beta-naphthylamidase MeSH D08.811.277.656.675.555.750 – lysine carboxypeptidase MeSH D08.811.277.656.837 – proprotein convertases MeSH D08.811.277.656.837.124 – carboxypeptidase h MeSH D08.811.277.656.837.186 – carboxypeptidase u MeSH D08.811.277.656.837.249 – furin MeSH D08.811.277.656.837.500 – proprotein convertase 1 MeSH D08.811.277.656.837.562 – proprotein convertase 2 MeSH D08.811.277.656.837.625 – proprotein convertase 5 MeSH D08.811.277.656.837.750 – renin MeSH D08.811.277.656.918 – proteasome endopeptidase complex
The analyte molecules in a sample can be partially ordered with respect to the external magnetic field of the spectrometer by manipulating the sample conditions. Common techniques include addition of bacteriophages or bicelles to the sample, or preparation of the sample in a stretched polyacrylamide gel. This creates a local environment that favours certain orientations of nonspherical molecules. Normally in solution NMR the dipolar couplings between nuclei are averaged out because of the fast tumbling of the molecule. The slight overpopulation of one orientation means that a residual dipolar coupling remains to be observed. The dipolar coupling is commonly used in solid state NMR and provides information about the relative orientation of the bond vectors relative to a single global reference frame. Typically the orientation of the N-H vector is probed in an HSQC-like experiment. Initially, residual dipolar couplings were used for refinement of previously determined structures, but attempts at de novo structure determination have also been made.
In the final, Zverev defeated Flavio Cobolli in a five-set contest, his longest match of the tournament by duration and sets played. With his win, Zverev became the first German men's singles champion since Henner Henkel in 1937, ending an 89 year drought. He became the first German male to win a major since Boris Becker in 1996 and joined Michael Stich and Becker to become the third German men's singles player to win a Major. In addition, he became the first player, male or female, to win a Major with Type 1 diabetes. Zverev rejoined the tour in Halle, reaching the semifinals just dropping one set to Vit Kopřiva in the second round. He lost the semifinal match to eventual finalist Taylor Fritz despite winning the first set, extending his ongoing losing streak against the American since Wimbledon 2024 to seven consecutive losses. During the 2026 Wimbledon, Zverev reached back-to-back second weeks of a major, and after defeating this time Taylor Fritz in the quarterfinal, and Arthur Fery in the semifinal, he made it to his second consecutive appearance in a Grand Slam final.. In the final, he lost to Sinner in four sets. Zverev lost his second round match to Tallon Griekspoor at the National Bank Open in 3 sets, then lost his 4th round match at the Cincinnati Masters to Tommy Paul in 3 sets. During the 2026 US Open, Zverev entered as the first seed following Jannik Sinner's withdrawal due to a knee injury. He nearly suffered a first-round defeat, being 2 points away from losing to Lorenzo Sonego in the 4th set while down two sets to one, and serving at 4-5, 30-30.
Sources: en.wikipedia.org
The Don Cossack Host (Russian: Всевеликое Войско Донское, Vsevelikoye Voysko Donskoye) was either an independent or an autonomous democratic republic, located in present-day Southern Russia. It existed from the end of the 16th century until the early 20th century. There are two main theories of the origin of the Don Cossacks. Most respected historians support the migration theory, according to which they were Slavic colonists. The various autochthonous theories popular among the Cossacks themselves do not find confirmation in genetic studies. The gene pool comprises mainly the East Slavic component, with a significant Ukrainian contribution. There is no influence of the peoples of the Caucasus; and the steppe populations, represented by the Nogais, have only limited impact. The majority of Don Cossacks are either Eastern Orthodox or Christian Old Believers (старообрядцы). Prior to the Russian Civil War, there were numerous religious minorities, including Muslims, Subbotniks, and Jews.
Glutathione peroxidase 5 (GPx-5), also known as epididymal secretory glutathione peroxidase, is an enzyme that in humans is encoded by the GPX5 gene. GPx-5 belongs to the glutathione peroxidase family. It is specifically expressed in the epididymis in the mammalian male reproductive tract, and is androgen-regulated. Unlike mRNAs for other characterized glutathione peroxidases, this mRNA does not contain a selenocysteine (UGA) codon. Thus, the encoded protein is selenium-independent, and has been proposed to play a role in protecting the membranes of spermatozoa from the damaging effects of lipid peroxidation and/or preventing premature acrosome reaction. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.
Drug metabolism is the metabolic breakdown of drugs by humans and animals, usually through specialized enzymatic systems. Drug metabolism represents a more specialized subset of xenobiotic metabolism (from the Greek xenos "stranger" and biotic "related to living beings") which also covers other foreign organic compounds such as pollutants or poisons in wider group of organisms that includes microorganisms, fungi, plants and animals. These reactions often act to detoxify drugs (although in some cases the intermediates in drug metabolism may cause toxic effects). The study of drug metabolism is one of the tenets of pharmacokinetics (PK) as metabolism (M), the fourth stage of LADME (a drug's transit through the body), involves the enzymatic biotransformation and non-enzymatic biotransformation of a drug, thereby leading to the fifth stage, excretion (E). The metabolism of pharmaceutical drugs is an important aspect of pharmacology and medicine. For example, the rate of metabolism determines the duration and intensity of a drug's pharmacologic action. Drug metabolism also affects multidrug resistance in infectious diseases and in chemotherapy for cancer, and the actions of some drugs as substrates or inhibitors of enzymes involved in xenobiotic metabolism are a common reason for hazardous drug interactions.
=== Takeshita === The Takeshita geometry consists of a 54.43° electric sector, and short drift length, a second electric sector of the same curvature direction followed by another drift length before a 180° magnetic sector of opposite curvature direction.
=== Availability === Chlorprothixene is widely available throughout Europe and elsewhere in the world. The drug was previously available in the United States under the brand name Taractan, but this formulation has since been discontinued and the drug is no longer available in this country.
Sources: en.wikipedia.org
Common approaches include enzymatic recycling assays, HPLC, and LC-MS/MS. Acid extraction and rapid processing limit oxidation before analysis.
Reduced glutathione oxidizes easily and can change after collection. Delays, warmth, light, and repeated freezing can alter measured values.
Labels may state total glutathione without specifying reduced and oxidized content. Purity, counterions, and actual assay can vary between products.
Common methods include spectrophotometric enzyme cycling assays, HPLC with UV or fluorescence detection, and LC-MS/MS. Detection often requires derivatization because glutathione lacks a strong chromophore. Method choice depends on the sample type and the required sensitivity.